Statins and prostate cancer
This article was originally published in The Tan Sheet
Statin use was associated with a 62% reduction in risk of prostate cancer after adjusting for risk factors, according to a case-control study published in the American Journal of Epidemiology Aug. 15. The risk reduction was especially notable for more aggressive forms of the disease, Jackilen Shannon, Oregon Health & Sciences University, et al., stated. The authors compared statin use in 100 prostate cancer patients with use of the drug in 202 matched controls. Among the cancer patients, 36% had a record of statin use, compared to almost 50% in the control group....
You may also be interested in...
If demand-side pressures on the life science sector were not enough, generic price erosion, debt repayment and extended restructurings are worsening the generic pharmaceutical investment proposition.
California state Attorney General Xavier Becerra promised during two US Senate committee hearings that, if confirmed as Secretary of Health and Human Services, he will let science shape HHS policy.
New treatments for advanced endometrial cancer and hereditary angioedema are among six drugs that have just been recommended for EU-wide approval. Harmonized EU advice has also been issued in relation to an investigational antibody combination for treating COVID-19.